14例急性心肌梗塞(AMI)并发心源性休克患者于发病6小时内给予150万单位尿激酶静脉内溶栓治疗。9例(64.4％)再通,再通者6例(66.7％)出院后存活,该6例远期随访7～13个月均存活。表明AMI并发心源性休克实行大剂量尿激酶溶栓治疗,可较明显地降低死亡率,改善预后,适合于基层医院开展。是基层医院治疗AMI并发心源性休克的一个好方法。 Fourteen patients with acute myocardial infarction (AMI) complicated with cardiogenic shock were given 1.5 million Urokinase intravenous thrombolysis within 6 hours of onset. Nine patients (64.4%) recanalized and recanalization survived after discharged from hospital in 6 patients (66.7%). All 6 patients were followed up for 7 to 13 months. That AMI complicated with cardiogenic shock with high-dose urokinase thrombolytic therapy can significantly reduce mortality and improve prognosis, suitable for primary hospital. It is a good way for primary hospitals to treat AMI complicated with cardiogenic shock.